MS
AMPE

Maven Securities’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Maven Securities’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-57
Closed -$29K – 1474
2021
Q1 		$29K Buy
+57
New +$29.4K ﹤0.01% 1129

Other funds holding AMPE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WIC
Willis Investment Counsel Gainesville, Georgia $1.83B AUM 15.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

Maven Securities's AMPE Position: Q2 2021 in Review

Maven Securities sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2021, closing a stake of 57 shares — an estimated $29K sold.

Maven Securities first reported a position in AMPE in Q1 2021 and held it in 1 quarter. The position peaked at $29K in Q1 2021. 128 funds tracked by Wall St. Rank hold AMPE as of Q2 2021.

  • Maven Securities reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2021 after selling out during the quarter.
  • Maven Securities sold 57 Ampio Pharmaceuticals Inc. shares in Q2 2021, an estimated $29K.
  • Maven Securities first reported a position in Ampio Pharmaceuticals Inc. in Q1 2021 and held it in 1 quarter.
  • Maven Securities's Ampio Pharmaceuticals Inc. position peaked at $29K in Q1 2021.
  • 128 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2021.

Based on Maven Securities's 13F filing for Q2 2021, filed 16 Aug 2021.